Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proto-Oncogene Proteins B-raf | 27 | 2022 | 2054 | 1.290 |
Why?
|
Thyroid Neoplasms | 18 | 2024 | 2354 | 1.030 |
Why?
|
Proto-Oncogene Proteins c-ret | 6 | 2021 | 228 | 0.990 |
Why?
|
Mutation | 56 | 2024 | 30209 | 0.970 |
Why?
|
Salivary Gland Neoplasms | 5 | 2022 | 306 | 0.860 |
Why?
|
Gene Rearrangement | 11 | 2021 | 1143 | 0.700 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 12 | 2023 | 904 | 0.610 |
Why?
|
DNA Mutational Analysis | 19 | 2021 | 4112 | 0.590 |
Why?
|
Proto-Oncogene Proteins c-kit | 5 | 2021 | 723 | 0.580 |
Why?
|
Drug Resistance, Neoplasm | 17 | 2024 | 5336 | 0.580 |
Why?
|
Carcinoma | 8 | 2020 | 2313 | 0.560 |
Why?
|
Vulvar Neoplasms | 2 | 2017 | 265 | 0.540 |
Why?
|
High-Throughput Nucleotide Sequencing | 16 | 2023 | 3665 | 0.540 |
Why?
|
Lung Neoplasms | 24 | 2023 | 13483 | 0.540 |
Why?
|
GTP Phosphohydrolases | 4 | 2016 | 524 | 0.530 |
Why?
|
Carcinoma, Merkel Cell | 3 | 2023 | 328 | 0.510 |
Why?
|
Phosphatidylinositol 3-Kinases | 10 | 2016 | 2877 | 0.470 |
Why?
|
Protein Kinase Inhibitors | 18 | 2020 | 5695 | 0.470 |
Why?
|
Immunohistochemistry | 20 | 2024 | 11035 | 0.470 |
Why?
|
Melanoma | 9 | 2024 | 5695 | 0.460 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 12 | 2023 | 5388 | 0.450 |
Why?
|
In Situ Hybridization, Fluorescence | 19 | 2022 | 2510 | 0.450 |
Why?
|
ras Proteins | 9 | 2014 | 1054 | 0.420 |
Why?
|
Proto-Oncogene Proteins | 13 | 2023 | 4521 | 0.410 |
Why?
|
Adenocarcinoma | 12 | 2021 | 6363 | 0.410 |
Why?
|
Carcinoma, Ductal | 1 | 2012 | 97 | 0.400 |
Why?
|
Oncogene Proteins, Fusion | 8 | 2024 | 1609 | 0.380 |
Why?
|
Carcinoma, Mucoepidermoid | 2 | 2022 | 91 | 0.370 |
Why?
|
Genotype | 12 | 2014 | 13028 | 0.360 |
Why?
|
Astrocytoma | 3 | 2013 | 772 | 0.350 |
Why?
|
Gene Fusion | 3 | 2022 | 357 | 0.330 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 15 | 2023 | 1765 | 0.330 |
Why?
|
Sweat Gland Neoplasms | 1 | 2011 | 109 | 0.320 |
Why?
|
Neoplasm Metastasis | 6 | 2020 | 4887 | 0.320 |
Why?
|
Glioma | 6 | 2014 | 3491 | 0.320 |
Why?
|
Receptor Protein-Tyrosine Kinases | 7 | 2022 | 1621 | 0.310 |
Why?
|
Skin Neoplasms | 8 | 2024 | 5836 | 0.300 |
Why?
|
Tumor Suppressor Protein p53 | 9 | 2018 | 2946 | 0.280 |
Why?
|
Neoplasms | 7 | 2022 | 22344 | 0.270 |
Why?
|
Isocitrate Dehydrogenase | 4 | 2015 | 954 | 0.270 |
Why?
|
PTEN Phosphohydrolase | 3 | 2024 | 1117 | 0.260 |
Why?
|
Membrane Proteins | 6 | 2021 | 7850 | 0.250 |
Why?
|
Carcinoma, Papillary, Follicular | 2 | 2017 | 60 | 0.250 |
Why?
|
Neoplasm Staging | 10 | 2024 | 11200 | 0.250 |
Why?
|
Adenocarcinoma, Follicular | 3 | 2017 | 323 | 0.240 |
Why?
|
DNA, Neoplasm | 5 | 2019 | 1739 | 0.240 |
Why?
|
Aged, 80 and over | 34 | 2021 | 59515 | 0.240 |
Why?
|
Acrylamides | 2 | 2018 | 260 | 0.240 |
Why?
|
Pyrazoles | 6 | 2020 | 2031 | 0.240 |
Why?
|
Genes, ras | 5 | 2017 | 656 | 0.230 |
Why?
|
Molecular Diagnostic Techniques | 4 | 2020 | 614 | 0.230 |
Why?
|
MAP Kinase Signaling System | 3 | 2018 | 1490 | 0.220 |
Why?
|
RNA-Binding Protein FUS | 1 | 2024 | 77 | 0.220 |
Why?
|
Antineoplastic Agents | 13 | 2020 | 13635 | 0.220 |
Why?
|
Aged | 50 | 2024 | 171219 | 0.220 |
Why?
|
Brain Neoplasms | 8 | 2019 | 9065 | 0.220 |
Why?
|
Neoplasms, Connective and Soft Tissue | 1 | 2023 | 34 | 0.220 |
Why?
|
Middle Aged | 56 | 2024 | 223083 | 0.210 |
Why?
|
Humans | 112 | 2024 | 766117 | 0.210 |
Why?
|
Gene Amplification | 6 | 2015 | 1088 | 0.210 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2024 | 115 | 0.210 |
Why?
|
Gastrointestinal Neoplasms | 3 | 2020 | 958 | 0.210 |
Why?
|
Tauopathies | 1 | 2006 | 325 | 0.210 |
Why?
|
Pyridines | 5 | 2020 | 2889 | 0.200 |
Why?
|
Penile Neoplasms | 1 | 2024 | 158 | 0.200 |
Why?
|
Tongue Neoplasms | 1 | 2024 | 185 | 0.200 |
Why?
|
Vitamin E | 1 | 2006 | 872 | 0.200 |
Why?
|
Nerve Degeneration | 1 | 2006 | 748 | 0.200 |
Why?
|
tau Proteins | 3 | 2007 | 2110 | 0.200 |
Why?
|
Small Cell Lung Carcinoma | 2 | 2018 | 453 | 0.190 |
Why?
|
Cullin Proteins | 3 | 2008 | 180 | 0.190 |
Why?
|
Thymoma | 1 | 2023 | 186 | 0.190 |
Why?
|
Pharmacy | 1 | 2023 | 92 | 0.190 |
Why?
|
Male | 66 | 2024 | 363935 | 0.190 |
Why?
|
Female | 73 | 2024 | 396233 | 0.190 |
Why?
|
Genes, p16 | 3 | 2016 | 157 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-ets | 2 | 2021 | 313 | 0.180 |
Why?
|
Carcinosarcoma | 2 | 2013 | 108 | 0.180 |
Why?
|
Polyomavirus Infections | 1 | 2023 | 193 | 0.180 |
Why?
|
Kaplan-Meier Estimate | 7 | 2017 | 6506 | 0.180 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2021 | 62 | 0.180 |
Why?
|
Adult | 46 | 2024 | 223139 | 0.180 |
Why?
|
Endometrial Stromal Tumors | 1 | 2021 | 46 | 0.180 |
Why?
|
Thymus Neoplasms | 1 | 2023 | 271 | 0.180 |
Why?
|
Aniline Compounds | 2 | 2018 | 1078 | 0.170 |
Why?
|
Sarcoma, Endometrial Stromal | 1 | 2021 | 92 | 0.170 |
Why?
|
Tumor Virus Infections | 1 | 2023 | 438 | 0.170 |
Why?
|
Cell Line, Tumor | 16 | 2019 | 17071 | 0.160 |
Why?
|
Sulfonamides | 3 | 2015 | 1980 | 0.160 |
Why?
|
Neoplasm Recurrence, Local | 9 | 2020 | 9378 | 0.160 |
Why?
|
Receptor, trkA | 1 | 2020 | 159 | 0.160 |
Why?
|
Carcinoma, Papillary | 4 | 2017 | 786 | 0.160 |
Why?
|
Young Adult | 21 | 2022 | 59868 | 0.160 |
Why?
|
MAP Kinase Kinase 1 | 4 | 2015 | 330 | 0.160 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2023 | 343 | 0.160 |
Why?
|
Ki-67 Antigen | 3 | 2016 | 628 | 0.160 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2020 | 329 | 0.150 |
Why?
|
Thrombocytosis | 1 | 2018 | 88 | 0.150 |
Why?
|
Benzimidazoles | 3 | 2013 | 862 | 0.150 |
Why?
|
Oncogenes | 3 | 2020 | 1232 | 0.150 |
Why?
|
Mutation, Missense | 8 | 2018 | 2590 | 0.150 |
Why?
|
Liver Neoplasms | 3 | 2023 | 4352 | 0.150 |
Why?
|
RNA-Binding Protein EWS | 1 | 2019 | 211 | 0.150 |
Why?
|
Colorectal Neoplasms | 5 | 2018 | 6961 | 0.150 |
Why?
|
Workflow | 1 | 2022 | 859 | 0.140 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2020 | 637 | 0.140 |
Why?
|
Oligodendroglioma | 1 | 2019 | 274 | 0.140 |
Why?
|
DNA, Mitochondrial | 2 | 2023 | 870 | 0.140 |
Why?
|
Protein Kinases | 4 | 2020 | 1611 | 0.140 |
Why?
|
Eosinophilia | 1 | 2022 | 553 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-met | 3 | 2016 | 562 | 0.140 |
Why?
|
Gene Dosage | 3 | 2016 | 1213 | 0.130 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2019 | 262 | 0.130 |
Why?
|
Signal Transduction | 7 | 2019 | 23605 | 0.130 |
Why?
|
Indoles | 2 | 2015 | 1833 | 0.130 |
Why?
|
Oxidative Stress | 1 | 2006 | 3140 | 0.120 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2017 | 218 | 0.120 |
Why?
|
Pituitary Neoplasms | 2 | 2014 | 1322 | 0.120 |
Why?
|
Disease-Free Survival | 5 | 2017 | 6840 | 0.120 |
Why?
|
Thyroid Nodule | 1 | 2022 | 765 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2019 | 2455 | 0.120 |
Why?
|
Cyst Fluid | 1 | 2015 | 86 | 0.120 |
Why?
|
Genetic Testing | 3 | 2014 | 3594 | 0.120 |
Why?
|
DNA Mismatch Repair | 1 | 2018 | 432 | 0.120 |
Why?
|
Soft Tissue Neoplasms | 1 | 2023 | 1163 | 0.120 |
Why?
|
Lactams, Macrocyclic | 1 | 2016 | 318 | 0.120 |
Why?
|
Oncogene Fusion | 1 | 2014 | 84 | 0.110 |
Why?
|
Receptor, erbB-2 | 4 | 2012 | 2593 | 0.110 |
Why?
|
Base Sequence | 4 | 2015 | 12405 | 0.110 |
Why?
|
Endometrial Neoplasms | 2 | 2021 | 1379 | 0.110 |
Why?
|
Pituitary Gland, Anterior | 1 | 2014 | 142 | 0.110 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2016 | 447 | 0.110 |
Why?
|
Polymerase Chain Reaction | 6 | 2017 | 6059 | 0.110 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2021 | 921 | 0.110 |
Why?
|
Frameshift Mutation | 1 | 2015 | 392 | 0.110 |
Why?
|
Adrenal Cortex | 1 | 2014 | 134 | 0.110 |
Why?
|
Medical Oncology | 2 | 2022 | 2339 | 0.110 |
Why?
|
Biliary Tract Neoplasms | 1 | 2015 | 186 | 0.110 |
Why?
|
Prognosis | 11 | 2021 | 29912 | 0.110 |
Why?
|
Genes, p53 | 1 | 2015 | 711 | 0.110 |
Why?
|
Lymph Nodes | 2 | 2017 | 3456 | 0.110 |
Why?
|
Point Mutation | 3 | 2013 | 1591 | 0.110 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2015 | 195 | 0.100 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2022 | 3637 | 0.100 |
Why?
|
Hepatoblastoma | 1 | 2013 | 90 | 0.100 |
Why?
|
Mutagenesis, Insertional | 1 | 2015 | 663 | 0.100 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2019 | 2057 | 0.100 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2013 | 97 | 0.100 |
Why?
|
Apocrine Glands | 1 | 2012 | 31 | 0.100 |
Why?
|
Glutarates | 1 | 2014 | 243 | 0.100 |
Why?
|
Genes, erbB-1 | 2 | 2015 | 161 | 0.100 |
Why?
|
Myeloproliferative Disorders | 1 | 2018 | 615 | 0.100 |
Why?
|
Sarcoma | 1 | 2023 | 1801 | 0.100 |
Why?
|
Eccrine Glands | 1 | 2012 | 52 | 0.100 |
Why?
|
Neoplasm Proteins | 3 | 2015 | 3594 | 0.100 |
Why?
|
Enzyme Activation | 4 | 2012 | 3584 | 0.100 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2023 | 2425 | 0.100 |
Why?
|
Pancreatic Neoplasms | 3 | 2015 | 5454 | 0.100 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2015 | 1762 | 0.100 |
Why?
|
Thyroidectomy | 4 | 2020 | 912 | 0.100 |
Why?
|
Chromosome Aberrations | 1 | 2018 | 1775 | 0.100 |
Why?
|
Cytodiagnosis | 1 | 2015 | 450 | 0.100 |
Why?
|
raf Kinases | 1 | 2012 | 116 | 0.090 |
Why?
|
Nevus, Blue | 1 | 2011 | 43 | 0.090 |
Why?
|
Pancreatic Cyst | 1 | 2015 | 373 | 0.090 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2012 | 252 | 0.090 |
Why?
|
BRCA1 Protein | 1 | 2018 | 1155 | 0.090 |
Why?
|
Repressor Proteins | 2 | 2021 | 2974 | 0.090 |
Why?
|
Translocation, Genetic | 4 | 2022 | 1393 | 0.090 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2011 | 615 | 0.090 |
Why?
|
bcl-X Protein | 1 | 2012 | 412 | 0.090 |
Why?
|
Craniopharyngioma | 1 | 2014 | 276 | 0.090 |
Why?
|
Wilms Tumor | 1 | 2013 | 378 | 0.090 |
Why?
|
Retrospective Studies | 15 | 2024 | 81565 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2023 | 2327 | 0.090 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2013 | 2898 | 0.090 |
Why?
|
Parietal Lobe | 1 | 2015 | 859 | 0.090 |
Why?
|
Intraoperative Care | 1 | 2014 | 768 | 0.090 |
Why?
|
Exons | 1 | 2016 | 2393 | 0.090 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2011 | 307 | 0.090 |
Why?
|
Pulmonary Fibrosis | 1 | 2014 | 503 | 0.090 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2011 | 310 | 0.090 |
Why?
|
Gallbladder Neoplasms | 1 | 2011 | 190 | 0.080 |
Why?
|
Gliosis | 1 | 2011 | 247 | 0.080 |
Why?
|
Phosphoproteins | 1 | 2018 | 2445 | 0.080 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2015 | 731 | 0.080 |
Why?
|
Radiology | 1 | 2023 | 2105 | 0.080 |
Why?
|
Germ-Line Mutation | 1 | 2018 | 1885 | 0.080 |
Why?
|
Hamartoma | 1 | 2011 | 235 | 0.080 |
Why?
|
Receptors, Growth Factor | 1 | 2010 | 324 | 0.080 |
Why?
|
Esophagogastric Junction | 1 | 2011 | 350 | 0.080 |
Why?
|
Phosphorylation | 5 | 2011 | 8292 | 0.080 |
Why?
|
Eligibility Determination | 1 | 2012 | 422 | 0.080 |
Why?
|
Transcription Factors | 4 | 2022 | 12130 | 0.070 |
Why?
|
Lymphoma, Follicular | 1 | 2012 | 459 | 0.070 |
Why?
|
Antibodies, Monoclonal | 3 | 2014 | 9237 | 0.070 |
Why?
|
Radiation Pneumonitis | 1 | 2008 | 98 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2008 | 205 | 0.070 |
Why?
|
Sex Cord-Gonadal Stromal Tumors | 1 | 2009 | 117 | 0.070 |
Why?
|
Proline-Directed Protein Kinases | 1 | 2007 | 2 | 0.070 |
Why?
|
Carcinoma, Basal Cell | 1 | 2013 | 565 | 0.070 |
Why?
|
Pneumonectomy | 1 | 2014 | 1147 | 0.070 |
Why?
|
Mice, SCID | 3 | 2019 | 2626 | 0.070 |
Why?
|
Barrett Esophagus | 1 | 2011 | 494 | 0.070 |
Why?
|
DNA-Binding Proteins | 4 | 2022 | 9601 | 0.070 |
Why?
|
Paraquat | 1 | 2006 | 36 | 0.070 |
Why?
|
Meningioma | 1 | 2016 | 1221 | 0.070 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2011 | 521 | 0.070 |
Why?
|
Mass Spectrometry | 1 | 2014 | 2195 | 0.070 |
Why?
|
Leupeptins | 1 | 2006 | 112 | 0.070 |
Why?
|
Adenoma | 1 | 2017 | 2155 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2019 | 3604 | 0.070 |
Why?
|
Meningeal Neoplasms | 1 | 2016 | 1252 | 0.070 |
Why?
|
Cohort Studies | 11 | 2020 | 41684 | 0.070 |
Why?
|
Pyrimidines | 2 | 2016 | 3050 | 0.070 |
Why?
|
Cholangiocarcinoma | 1 | 2011 | 577 | 0.060 |
Why?
|
Bile Duct Neoplasms | 1 | 2011 | 624 | 0.060 |
Why?
|
Survival Analysis | 5 | 2019 | 10087 | 0.060 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2011 | 1150 | 0.060 |
Why?
|
Diagnostic Tests, Routine | 1 | 2011 | 789 | 0.060 |
Why?
|
Co-Repressor Proteins | 2 | 2021 | 190 | 0.060 |
Why?
|
Quinazolines | 2 | 2011 | 1366 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2012 | 1407 | 0.060 |
Why?
|
Molecular Targeted Therapy | 2 | 2020 | 2824 | 0.060 |
Why?
|
Neoplasm Invasiveness | 4 | 2017 | 3602 | 0.060 |
Why?
|
Genital Neoplasms, Female | 1 | 2010 | 534 | 0.060 |
Why?
|
Myelodysplastic Syndromes | 1 | 2015 | 1404 | 0.060 |
Why?
|
Lung Diseases, Interstitial | 1 | 2014 | 940 | 0.060 |
Why?
|
Lymphatic Metastasis | 3 | 2024 | 2890 | 0.060 |
Why?
|
Etoposide | 1 | 2006 | 636 | 0.060 |
Why?
|
Breast Neoplasms | 4 | 2024 | 21074 | 0.060 |
Why?
|
Sentinel Lymph Node Biopsy | 2 | 2024 | 733 | 0.060 |
Why?
|
Rectal Neoplasms | 1 | 2014 | 1183 | 0.060 |
Why?
|
Clinical Laboratory Techniques | 1 | 2010 | 746 | 0.060 |
Why?
|
Amino Acid Substitution | 3 | 2014 | 1742 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5367 | 0.060 |
Why?
|
Smad4 Protein | 2 | 2015 | 194 | 0.060 |
Why?
|
Mesenchymoma | 1 | 2024 | 50 | 0.060 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2005 | 370 | 0.060 |
Why?
|
Glioblastoma | 1 | 2019 | 3458 | 0.060 |
Why?
|
Genetic Heterogeneity | 2 | 2019 | 735 | 0.060 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2024 | 193 | 0.050 |
Why?
|
Survival Rate | 5 | 2020 | 12827 | 0.050 |
Why?
|
Lipid Peroxides | 1 | 2023 | 73 | 0.050 |
Why?
|
Treatment Outcome | 6 | 2020 | 65219 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 1 | 2013 | 2795 | 0.050 |
Why?
|
Mice, Nude | 3 | 2018 | 3610 | 0.050 |
Why?
|
Crohn Disease | 1 | 2016 | 2281 | 0.050 |
Why?
|
Adolescent | 9 | 2021 | 88819 | 0.050 |
Why?
|
Oxyphil Cells | 1 | 2023 | 55 | 0.050 |
Why?
|
Ubiquitin | 1 | 2008 | 840 | 0.050 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2024 | 259 | 0.050 |
Why?
|
Fermentation | 1 | 2023 | 141 | 0.050 |
Why?
|
S100 Proteins | 1 | 2023 | 214 | 0.050 |
Why?
|
Neurotoxicity Syndromes | 1 | 2007 | 302 | 0.050 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2024 | 220 | 0.050 |
Why?
|
Carcinoma in Situ | 1 | 2008 | 777 | 0.050 |
Why?
|
Bone Neoplasms | 1 | 2015 | 2559 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2024 | 15403 | 0.050 |
Why?
|
Genetic Variation | 2 | 2017 | 6612 | 0.050 |
Why?
|
Gene Expression Profiling | 3 | 2014 | 9527 | 0.050 |
Why?
|
Cell Proliferation | 3 | 2016 | 10433 | 0.050 |
Why?
|
Phenotype | 6 | 2020 | 16716 | 0.050 |
Why?
|
Drosophila | 2 | 2007 | 1506 | 0.050 |
Why?
|
Molecular Sequence Data | 2 | 2014 | 17597 | 0.050 |
Why?
|
Biopsy, Fine-Needle | 2 | 2017 | 1131 | 0.050 |
Why?
|
Colonic Neoplasms | 1 | 2014 | 2532 | 0.050 |
Why?
|
Receptor, IGF Type 2 | 1 | 2021 | 35 | 0.050 |
Why?
|
Sequence Analysis, DNA | 4 | 2015 | 4780 | 0.050 |
Why?
|
Clinical Trials as Topic | 3 | 2012 | 8038 | 0.050 |
Why?
|
Mice | 12 | 2019 | 81839 | 0.050 |
Why?
|
Fetal Growth Retardation | 1 | 2005 | 591 | 0.050 |
Why?
|
Thyroid Function Tests | 1 | 2022 | 289 | 0.050 |
Why?
|
Inhibitory Concentration 50 | 2 | 2013 | 463 | 0.050 |
Why?
|
Disease Progression | 4 | 2020 | 13616 | 0.050 |
Why?
|
Esophageal Neoplasms | 1 | 2011 | 1659 | 0.040 |
Why?
|
Stomach Neoplasms | 1 | 2011 | 1471 | 0.040 |
Why?
|
Prospective Studies | 7 | 2022 | 54812 | 0.040 |
Why?
|
Smoking | 2 | 2015 | 9082 | 0.040 |
Why?
|
Drug Resistance | 1 | 2006 | 1592 | 0.040 |
Why?
|
Ribonuclease III | 1 | 2022 | 271 | 0.040 |
Why?
|
Mice, Inbred NOD | 2 | 2015 | 1837 | 0.040 |
Why?
|
Animals | 15 | 2019 | 168800 | 0.040 |
Why?
|
Algorithms | 1 | 2021 | 14066 | 0.040 |
Why?
|
Uterine Neoplasms | 1 | 2009 | 1425 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 11859 | 0.040 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2023 | 385 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2015 | 634 | 0.040 |
Why?
|
Drug Delivery Systems | 1 | 2011 | 2210 | 0.040 |
Why?
|
DEAD-box RNA Helicases | 1 | 2022 | 386 | 0.040 |
Why?
|
Immunophenotyping | 2 | 2016 | 1865 | 0.040 |
Why?
|
Apoptosis | 3 | 2015 | 9508 | 0.040 |
Why?
|
Estrogen Receptor alpha | 1 | 2023 | 580 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2016 | 8612 | 0.040 |
Why?
|
Haploidy | 1 | 2018 | 128 | 0.040 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2018 | 101 | 0.040 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2019 | 237 | 0.040 |
Why?
|
Cytogenetic Analysis | 1 | 2018 | 270 | 0.040 |
Why?
|
Genomics | 1 | 2014 | 5926 | 0.040 |
Why?
|
Gene Expression | 2 | 2010 | 7582 | 0.040 |
Why?
|
Time Factors | 4 | 2024 | 40108 | 0.040 |
Why?
|
Gene Frequency | 2 | 2015 | 3623 | 0.030 |
Why?
|
beta Catenin | 2 | 2014 | 1047 | 0.030 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2017 | 109 | 0.030 |
Why?
|
Follow-Up Studies | 5 | 2020 | 39243 | 0.030 |
Why?
|
Iodine Radioisotopes | 1 | 2020 | 1029 | 0.030 |
Why?
|
Thyroid Gland | 1 | 2023 | 1168 | 0.030 |
Why?
|
Biopsy | 3 | 2014 | 6768 | 0.030 |
Why?
|
Cell Survival | 2 | 2016 | 5747 | 0.030 |
Why?
|
Blotting, Western | 2 | 2015 | 5020 | 0.030 |
Why?
|
Sequence Deletion | 2 | 2013 | 1494 | 0.030 |
Why?
|
RNA, Small Interfering | 3 | 2010 | 3424 | 0.030 |
Why?
|
Autopsy | 1 | 2019 | 1011 | 0.030 |
Why?
|
Lactams | 1 | 2016 | 159 | 0.030 |
Why?
|
Neck Dissection | 1 | 2017 | 201 | 0.030 |
Why?
|
Cystadenoma | 1 | 2015 | 76 | 0.030 |
Why?
|
Neovascularization, Pathologic | 2 | 2015 | 2627 | 0.030 |
Why?
|
Nerve Tissue Proteins | 2 | 2022 | 4399 | 0.030 |
Why?
|
Genetic Association Studies | 2 | 2016 | 2744 | 0.030 |
Why?
|
Disease Models, Animal | 3 | 2015 | 18321 | 0.030 |
Why?
|
Databases, Factual | 2 | 2021 | 8062 | 0.030 |
Why?
|
North America | 1 | 2018 | 1287 | 0.030 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2015 | 68 | 0.030 |
Why?
|
Biliary Tract | 1 | 2015 | 137 | 0.030 |
Why?
|
Chromogranins | 1 | 2015 | 159 | 0.030 |
Why?
|
Genes, erbB-2 | 1 | 2015 | 161 | 0.030 |
Why?
|
In Situ Nick-End Labeling | 1 | 2015 | 610 | 0.030 |
Why?
|
False Negative Reactions | 1 | 2015 | 570 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2016 | 474 | 0.030 |
Why?
|
Bile Ducts | 1 | 2015 | 288 | 0.030 |
Why?
|
Carcinoembryonic Antigen | 1 | 2015 | 336 | 0.030 |
Why?
|
Aphasia | 1 | 2015 | 193 | 0.030 |
Why?
|
Child | 5 | 2019 | 80573 | 0.030 |
Why?
|
Microsatellite Repeats | 1 | 2016 | 784 | 0.030 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2015 | 303 | 0.030 |
Why?
|
Sulfones | 1 | 2016 | 447 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2015 | 195 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2003 | 2430 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2014 | 12529 | 0.030 |
Why?
|
DNA Methylation | 2 | 2019 | 4425 | 0.030 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2014 | 355 | 0.030 |
Why?
|
Telomerase | 1 | 2018 | 749 | 0.030 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2014 | 182 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2018 | 1322 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2008 | 4049 | 0.030 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2015 | 520 | 0.030 |
Why?
|
Trans-Activators | 1 | 2022 | 2849 | 0.030 |
Why?
|
Aminopyridines | 1 | 2016 | 576 | 0.020 |
Why?
|
Animals, Genetically Modified | 2 | 2007 | 1563 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2015 | 702 | 0.020 |
Why?
|
Chemokine CXCL12 | 1 | 2014 | 455 | 0.020 |
Why?
|
Adenocarcinoma, Papillary | 1 | 2012 | 86 | 0.020 |
Why?
|
Antibody Specificity | 1 | 2014 | 1061 | 0.020 |
Why?
|
Remission Induction | 1 | 2018 | 2413 | 0.020 |
Why?
|
Consensus | 1 | 2022 | 3202 | 0.020 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2012 | 80 | 0.020 |
Why?
|
HT29 Cells | 1 | 2012 | 187 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2003 | 3606 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2013 | 487 | 0.020 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2012 | 103 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 3 | 2020 | 18076 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 16040 | 0.020 |
Why?
|
Valine | 1 | 2013 | 410 | 0.020 |
Why?
|
Brain Edema | 1 | 2015 | 601 | 0.020 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2011 | 88 | 0.020 |
Why?
|
Cardia | 1 | 2011 | 61 | 0.020 |
Why?
|
Tissue Embedding | 1 | 2011 | 43 | 0.020 |
Why?
|
Craniotomy | 1 | 2015 | 737 | 0.020 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2012 | 148 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2012 | 380 | 0.020 |
Why?
|
DNA-Cytosine Methylases | 1 | 2010 | 17 | 0.020 |
Why?
|
Tumor Burden | 1 | 2017 | 1889 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2010 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2020 | 2702 | 0.020 |
Why?
|
Pyrimidinones | 1 | 2013 | 384 | 0.020 |
Why?
|
Sex Factors | 2 | 2015 | 10614 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2012 | 715 | 0.020 |
Why?
|
Pulmonary Alveoli | 1 | 2013 | 665 | 0.020 |
Why?
|
Stem Cells | 1 | 2003 | 3537 | 0.020 |
Why?
|
Cell Nucleus | 2 | 2013 | 2864 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2018 | 2045 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2011 | 544 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2013 | 12061 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2017 | 12976 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2018 | 1897 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2015 | 1743 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2014 | 2915 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2012 | 8525 | 0.020 |
Why?
|
Pancreas | 1 | 2015 | 1699 | 0.020 |
Why?
|
Molecular Biology | 1 | 2012 | 573 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3801 | 0.020 |
Why?
|
Child, Preschool | 3 | 2019 | 42511 | 0.020 |
Why?
|
Hepatocyte Growth Factor | 1 | 2010 | 268 | 0.020 |
Why?
|
Vision Disorders | 1 | 2015 | 1087 | 0.020 |
Why?
|
Quinazolinones | 1 | 2010 | 219 | 0.020 |
Why?
|
Neurons | 1 | 2007 | 9521 | 0.020 |
Why?
|
Melanocytes | 1 | 2011 | 504 | 0.020 |
Why?
|
Drosophila Proteins | 2 | 2007 | 1704 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1512 | 0.020 |
Why?
|
Transfection | 1 | 2015 | 5739 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2013 | 2844 | 0.020 |
Why?
|
Pyridones | 1 | 2013 | 817 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2022 | 5791 | 0.020 |
Why?
|
Pathology, Molecular | 1 | 2010 | 329 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3796 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2013 | 1181 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2014 | 1756 | 0.020 |
Why?
|
DNA Topoisomerase IV | 1 | 2006 | 42 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 473 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2014 | 36548 | 0.020 |
Why?
|
Microsatellite Instability | 1 | 2010 | 726 | 0.020 |
Why?
|
F-Box Proteins | 1 | 2008 | 199 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2008 | 478 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2014 | 1996 | 0.020 |
Why?
|
DNA Primers | 1 | 2010 | 2824 | 0.020 |
Why?
|
Isoenzymes | 1 | 2011 | 1688 | 0.020 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2008 | 558 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2016 | 4249 | 0.020 |
Why?
|
CpG Islands | 1 | 2010 | 1207 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2014 | 2353 | 0.020 |
Why?
|
S-Phase Kinase-Associated Proteins | 1 | 2005 | 84 | 0.020 |
Why?
|
Alzheimer Disease | 1 | 2006 | 8724 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2007 | 1724 | 0.020 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2007 | 938 | 0.020 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2007 | 415 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5784 | 0.010 |
Why?
|
SKP Cullin F-Box Protein Ligases | 1 | 2005 | 173 | 0.010 |
Why?
|
Ovarian Neoplasms | 2 | 2013 | 4904 | 0.010 |
Why?
|
Alanine | 1 | 2007 | 613 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2014 | 2838 | 0.010 |
Why?
|
Precancerous Conditions | 1 | 2011 | 975 | 0.010 |
Why?
|
Alleles | 1 | 2015 | 6892 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10737 | 0.010 |
Why?
|
Codon, Nonsense | 1 | 2005 | 288 | 0.010 |
Why?
|
Fibroblasts | 1 | 2014 | 4162 | 0.010 |
Why?
|
Cell Line | 2 | 2008 | 15546 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14747 | 0.010 |
Why?
|
Radiography | 1 | 2014 | 6943 | 0.010 |
Why?
|
Eye | 1 | 2007 | 710 | 0.010 |
Why?
|
Gastrula | 1 | 2003 | 83 | 0.010 |
Why?
|
Papillomaviridae | 1 | 2008 | 1137 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4565 | 0.010 |
Why?
|
Endoderm | 1 | 2003 | 165 | 0.010 |
Why?
|
Cytoplasm | 1 | 2006 | 1498 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2010 | 6208 | 0.010 |
Why?
|
Protein Interaction Mapping | 1 | 2005 | 619 | 0.010 |
Why?
|
Radiotherapy | 1 | 2008 | 1491 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8882 | 0.010 |
Why?
|
Amino Acids | 1 | 2007 | 1710 | 0.010 |
Why?
|
Genome, Human | 1 | 2014 | 4443 | 0.010 |
Why?
|
Xenopus | 1 | 2003 | 709 | 0.010 |
Why?
|
Homozygote | 1 | 2005 | 1774 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2008 | 6102 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2006 | 1318 | 0.010 |
Why?
|
Patient Selection | 1 | 2012 | 4249 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2011 | 3048 | 0.010 |
Why?
|
Tretinoin | 1 | 2003 | 524 | 0.010 |
Why?
|
Mesoderm | 1 | 2003 | 679 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2008 | 3733 | 0.010 |
Why?
|
Cell Cycle | 1 | 2007 | 2920 | 0.010 |
Why?
|
Up-Regulation | 1 | 2008 | 4133 | 0.010 |
Why?
|
Syndrome | 1 | 2005 | 3270 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 22228 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3751 | 0.010 |
Why?
|
Drosophila melanogaster | 1 | 2007 | 1725 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 14645 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6545 | 0.010 |
Why?
|
Logistic Models | 1 | 2012 | 13273 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2005 | 4617 | 0.010 |
Why?
|
Risk Factors | 2 | 2014 | 74857 | 0.010 |
Why?
|
Age Factors | 1 | 2013 | 18386 | 0.010 |
Why?
|
Papillomavirus Infections | 1 | 2008 | 1637 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11906 | 0.010 |
Why?
|
Protein Binding | 1 | 2006 | 9301 | 0.010 |
Why?
|
Intestines | 1 | 2003 | 1904 | 0.010 |
Why?
|
United States | 1 | 2022 | 72920 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2008 | 14456 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2010 | 20137 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2005 | 4910 | 0.010 |
Why?
|
Brain | 1 | 2019 | 27177 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2012 | 26381 | 0.010 |
Why?
|
Risk Assessment | 1 | 2013 | 24276 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20700 | 0.010 |
Why?
|
Infant | 1 | 2012 | 36427 | 0.010 |
Why?
|
Lung | 1 | 2008 | 10063 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2003 | 7600 | 0.000 |
Why?
|
Cells, Cultured | 1 | 2003 | 18967 | 0.000 |
Why?
|
Cell Differentiation | 1 | 2003 | 11642 | 0.000 |
Why?
|